Remove Diabetes Remove Pharmacy Management Remove Seminar
article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

Azurity Pharmaceuticals announces the FDA approval of XIFYRM™ (meloxicam injection) for the management of moderate-to-severe pain in adults. Seminars in Arthritis and Rheumatism. PR Newswire. June 10, 2025. Accessed June 10, 2025. Meloxicam: Selective COX-2 inhibition in clinical practice. December 21, 2004.

article thumbnail

Resident Mental Health Matters

Pharmacy Times

I did not understand what she meant until after I completed my fall seminar. My preceptor said, “[Because] you finished your fall seminar, your goal this weekend is to take a break for a day and to take some time to celebrate your accomplishment.”

article thumbnail

Monitoring Nutrition Is Crucial in Cardiovascular Disease Management

Pharmacy Times

Omega-3 fatty acids effects on inflammatory biomarkers and lipid profiles among diabetic and cardiovascular disease patients: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol. 2021;41(7):2190-2200. doi:10.1161/ATVBAHA.120.315628 120.315628 7. Natto ZS, Yaghmoor W, Alshaeri HK, Van Dyke TE. 2019;9(1):18867.